Omeprazole (A2845): Practical Lab Guidance for H+,K+-ATPase Inhibition

What This Product Solves

Omeprazole, identified chemically as 3-(quinolin-4-ylmethylamino)-N-[4-(trifluoromethoxy)phenyl]thiophene-2-carboxamide, is a benchmark tool for researchers investigating the mechanisms of gastric acid secretion and the development of antiulcer strategies. Its primary application is as a potent H+,K+-ATPase inhibitor—the molecular target that underlies gastric acid production in parietal cells. With a validated IC50 of 5.8 μM for the proton pump and 0.16 μM for histamine-induced acid formation (source: product_spec), Omeprazole offers predictable, titratable inhibition for in vitro and preclinical peptic ulcer disease models, as well as gastric acid-related disorder research. Its workflow value is rooted in high compound purity (approx. 98%) and standardized QC, supporting reproducibility in both mechanistic and pharmacological studies.

For deeper insight into Omeprazole’s integration in antiulcer research workflows, see the related internal article, "Optimizing Antiulcer Research with 3-(quinolin-4-ylmethylamino)-N-[4-(trifluoromethoxy)phenyl]thiophene-2-carboxamide", which details streamlined setup and troubleshooting strategies.

Protocol Parameters

• assay: H+,K+-ATPase inhibition | value_with_unit: IC50 = 5.8 μM | applicability: Quantifying inhibition potency in proton pump assays | rationale: Establishes a reference for dose-response profiling and benchmarking inhibitor selectivity | source_type: product_spec (link)
• assay: Histamine-induced gastric acid formation | value_with_unit: IC50 = 0.16 μM | applicability: Modeling acid secretion in cell-based or ex vivo systems | rationale: Enables assessment of acid suppression in response to relevant physiological stimuli | source_type: product_spec (link)
• assay: Compound solubility in DMSO | value_with_unit: ≥17.27 mg/mL | applicability: Preparation of stock solutions for in vitro experimentation | rationale: DMSO is the recommended solvent due to compound's insolubility in water and ethanol; ensures solution homogeneity and reproducibility | source_type: product_spec (link)
• assay: Storage conditions (solid) | value_with_unit: -20°C | applicability: Maintaining compound stability and integrity | rationale: Solid-state storage at -20°C is recommended for long-term preservation; solution forms degrade over time | source_type: product_spec (link)
• assay: Shipping temperature | value_with_unit: Blue ice | applicability: Preserving sample quality during transport | rationale: Minimizes risk of thermal degradation of small molecule | source_type: product_spec (link)

Workflow Setup and QC Checklist

For best-practice results in gastric acid secretion research, attention to compound handling, solubilization, and assay design is critical:

1. Stock Solution Preparation: Dissolve Omeprazole in DMSO to create a concentrated stock (recommend ≥10 mg/mL). Confirm complete dissolution by visual inspection; avoid water or ethanol as solvents due to insolubility (source: product_spec).
2. Aliquoting and Storage: Dispense into small aliquots to minimize freeze-thaw cycles. Store stocks as solid at -20°C; avoid long-term storage of liquid solutions to maintain compound integrity.
3. Assay Controls: Include DMSO-only controls in each experiment, as DMSO is the solvent vehicle. Account for final DMSO concentration in cell-based or ex vivo systems to prevent confounding effects.
4. Purity Verification: Document lot-specific purity (approx. 98%) before each experimental run. If applicable, perform independent QC (e.g., HPLC) to confirm identity and purity per internal lab SOPs.
5. Temperature Management: Ensure shipping on blue ice has been maintained upon receipt. Inspect for condensation or signs of temperature excursions on arrival.
6. Documentation: Record all lot numbers, preparation details, and storage conditions for reproducibility and compliance.

For further workflow guidance, the internal article "Omeprazole: Precision H+,K+-ATPase Inhibitor for Gastric ..." outlines detailed integration steps and clarifies the compound’s operational boundaries in lab research.

Common Failure Modes and Fixes

• Incomplete Dissolution: If undissolved particles are observed during stock preparation, verify DMSO quality and gently warm (not exceeding 37°C) to promote solubilization. Do not use alternative solvents such as water or ethanol, as Omeprazole is insoluble in these (source: product_spec).
• Precipitation in Working Solutions: Dilution into aqueous buffers may lead to precipitation. Prepare fresh working dilutions immediately before use and avoid prolonged incubation at room temperature.
• Compound Degradation: If activity diminishes over time, check storage conditions. Discard solutions stored for extended periods; always return unused aliquots to -20°C promptly after each use.
• DMSO Toxicity to Cells: For cell-based assays, limit final DMSO concentration (typically ≤0.1–0.5%) to minimize cytotoxicity. Include vehicle controls to distinguish compound effects from solvent artifacts.
• Batch-to-Batch Variability: Cross-verify purity and identity across different lots, documenting all batch numbers and QC data in experimental notes.

Scope and Limitations

Omeprazole (A2845) is validated for research use as a selective inhibitor of the gastric proton pump for mechanistic studies of acid secretion, inhibitor profiling, and antiulcer activity modeling. Its solubility constraints—insoluble in water and ethanol—require exclusive use of DMSO for solution preparation. The compound is not intended for diagnostic, therapeutic, or clinical applications, and is unsuitable for workflows dependent on aqueous or ethanol-based systems. Long-term storage of Omeprazole in solution is not recommended due to stability concerns (source: product_spec).

Researchers should note that all numeric claims and workflow recommendations are derived solely from the product dossier and internal workflow best practices, not from peer-reviewed study data.

Conclusion

Omeprazole (A2845) is a well-characterized, high-purity H+,K+-ATPase inhibitor optimized for research applications in gastric acid secretion and antiulcer activity modeling. Its defined IC50 values, DMSO solubility, and robust QC make it suitable for controlled, reproducible laboratory studies. For complete technical specifications and ordering, refer to the official Omeprazole product page. For enhanced workflow design, APExBIO’s protocols and internal article links provide additional procedural context and troubleshooting support.